SHAH CAPITAL MANAGEMENT: NOVAVAX INC (NVAX): Quarterly 13F Position History
As of Q3 2026, SHAH CAPITAL MANAGEMENT reported 12,173,481 shares of NOVAVAX INC (NVAX), worth $131.6M and representing 21.7% of its 13F equity book. Quarter-over-quarter share count change: 1,992,096 (-14.1%) . The position first appeared in Q4 2022 and has been disclosed across 16 13F-HR filings in Pactolio's tracked window.
- 12,173,481Shares Held (Latest Filing)
- $131.6MReported Market Value (Latest Filing)
- 21.7%Portfolio Weight (% of 13F Equity Book)
- 1,992,096Quarter-over-Quarter Share Change
- -$1.8MQuarter-over-Quarter Value Change
- 14,845,097Peak Reported Shares (Historical)
Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 16 quarter s
| Quarter | Shares | QoQ Share Change | Share Change (%) | Market Value | Weight | Implied Price |
|---|---|---|---|---|---|---|
| Q3 2026 | 12,173,481 | 1,992,096 | -14.1% | $131.6M | 21.7% | $10.8 |
| Q2 2026 | 14,165,577 | 679,520 | -4.6% | $133.4M | 25.4% | $9.4 |
| Q1 2026 | 14,845,097 | +286,317 | +2.0% | $120.8M | 23.2% | $8.1 |
| Q4 2025 | 14,558,780 | +2,747,000 | +23.3% | $97.8M | 18.9% | $6.7 |
| Q3 2025 | 11,811,780 | +300,000 | +2.6% | $102.4M | 18.3% | $8.7 |
| Q2 2025 | 11,511,780 | +379,934 | +3.4% | $72.5M | 14.1% | $6.3 |
| Q1 2025 | 11,131,846 | 17,000 | -0.2% | $71.4M | 14.6% | $6.4 |
| Q4 2024 | 11,148,846 | +1,333,305 | +13.6% | $89.6M | 18.1% | $8.0 |
| Q3 2024 | 9,815,541 | +153,451 | +1.6% | $124.0M | 24.2% | $12.6 |
| Q2 2024 | 9,662,090 | +1,544,263 | +19.0% | $122.3M | 26.5% | $12.7 |
| Q1 2024 | 8,117,827 | +337,071 | +4.3% | $38.8M | 10.9% | $4.8 |
| Q4 2023 | 7,780,756 | +1,450,000 | +22.9% | $37.3M | 9.6% | $4.8 |
| Q3 2023 | 6,330,756 | +850,000 | +15.5% | $45.8M | 10.8% | $7.2 |
| Q2 2023 | 5,480,756 | +1,229,680 | +28.9% | $40.7M | 10.5% | $7.4 |
| Q1 2023 | 4,251,076 | +3,536,076 | +494.6% | $29.5M | 8.6% | $6.9 |
| Q4 2022 | 715,000 | – | – | $7.3M | 1.7% | $10.3 |
Methodology & FAQ
How This Position History Is Sourced
Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares, a quarter-end mark rather than the manager's cost basis. See the full methodology document for the normalization rules.
When did SHAH CAPITAL MANAGEMENT first disclose a NVAX position in 13F-HR filings?
SHAH CAPITAL MANAGEMENT first reported NOVAVAX INC (NVAX) on its 13F-HR filing for the period ending 2022-12-31 (Q4 2022). The position has appeared on 16 reported quarters within Pactolio's tracked window.
What was SHAH CAPITAL MANAGEMENT's most recent quarter-over-quarter share-count change in NVAX?
Between Q2 2026 and Q3 2026, SHAH CAPITAL MANAGEMENT reduced its NVAX position by 1,992,096 shares (-14.1%), leaving 12,173,481 shares at a market value of $131.6M.
Does the implied price-per-share represent SHAH CAPITAL MANAGEMENT's cost basis in NVAX?
No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.